Please wait a minute...
Reviews in Cardiovascular Medicine  2010, Vol. 11 Issue (S2): 51-65     DOI: 10.3909/ricm11S2S0002
Review Previous articles |
An Evidence-Based Algorithm for the Use of B-Type Natriuretic Testing in Acute Coronary Syndromes
Peter A. McCullough1, W. Frank Peacock2, Brian O'Neil3, James A. de Lemos4, Norman E. Lepor5, Robert Berkowitz6
1 Department of Medicine, Divisions of Cardiology, Nutrition, and Preventive Medicine, William Beaumont Hospital, Royal Oak, MI
2 Department of Emergency Medicine, The Cleveland Clinic, Cleveland, OH
3 Department of Emergency Medicine, Wayne State University School of Medicine, Detroit, MI
4 Donald W. Reynolds Cardiovascular Research Center, UT Southwestern Medical Center, Dallas, TX
5 Cedars Sinai Medical Center, Los Angeles, CA
6 Heart Failure Program, Hackensack University Medical Center, Hackensack, NJ
Download:  PDF(605KB)  ( 149 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Measurable B-type natriuretic peptides (BNPs), which are largely produced by the left ventricle, include BNP and N-terminal prohormone BNP (NT-proBNP). These proteins are released by cardiomyocytes in response to wall tension and neurohumoral signals, and are established tools in the diagnosis and prognosis of heart failure (HF). We identified 32 articles for entry into evidence tables that presented original data on BNP and/or NT-proBNP in more than 100 patients with acute coronary syndromes (ACS) presenting with chest discomfort with or without dyspnea. Natriuretic peptide (NP) elevation was associated with older age, female sex, hypertension, diabetes, prior HF, prior ischemic heart disease, and reduced renal function. Clinical correlates of elevated blood NP levels included left main or 3-vessel coronary disease, lipid-rich plaques with large necrotic cores in proximal locations, large zones of myocardial ischemia or infarction, no-reflow and impaired perfusion after percutaneous intervention, reduced left ventricular ejection fraction, higher Killip classification, and the development of cardiogenic shock. All studies indicated that after adjustment for baseline predictors and clinical risk scores, elevated NP concentrations were independently predictive of the development of HF and all-cause mortality. In contrast, studies did not consistently demonstrate that NPs were predictive of myocardial infarction and rehospitalization for ACS. In addition to baseline measurement, there is consensus that repeat testing at 4 to 12 weeks and 6 to 12 months in follow-up is helpful in the anticipation of late cardiac sequelae and may assist in assessing prognosis and guiding management.
Key words:  B-type natriuretic peptide      N-terminal pro-B-type natriuretic peptide      Acute coronary syndrome      Acute myocardial infarction      Diagnosis      Complications      Prognosis      Systematic review      Hospitalization      Mortality     
Published:  20 February 2010     

Cite this article: 

Peter A. McCullough, W. Frank Peacock, Brian O'Neil, James A. de Lemos, Norman E. Lepor, Robert Berkowitz. An Evidence-Based Algorithm for the Use of B-Type Natriuretic Testing in Acute Coronary Syndromes. Reviews in Cardiovascular Medicine, 2010, 11(S2): 51-65.

URL: 

https://rcm.imrpress.com/EN/10.3909/ricm11S2S0002     OR     https://rcm.imrpress.com/EN/Y2010/V11/IS2/51

[1] Gayatri Setia, Jeffrey Tyler, Alan Kwan, Josh Faguet, Shilpa Sharma, Siddharth Singh, Babak Azarbal, Rose Tompkins, Dinora Chinchilla, Sara Ghandehari. High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19[J]. Reviews in Cardiovascular Medicine, 2020, 21(2): 289-295.
[2] Peter A. McCullough, John Eidt, Janani Rangaswami, Edgar Lerma, James Tumlin, Kevin Wheelan, Nevin Katz, Norman E. Lepor, Kris Vijay, Sandeep Soman, Bhupinder Singh, Sean P. McCullough, Haley B. McCullough, Alberto Palazzuoli, Gaetano M. Ruocco, Claudio Ronco. Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 1-7.
[3] Akanksha Agrawal, Hafeez Ul Hassan Virk, Iqra Riaz, Deepanshu Jain, Byomesh Tripathi, Chayakrit Krittanawong, Benham Bozorgnia, Vincent Figueredo, Peter A. McCullough, Janani Rangaswami. Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study[J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 123-127.
[4] Shi-Min Yuan. Cardiac and vascular causes of persistent fever: A systematic review[J]. Reviews in Cardiovascular Medicine, 2019, 20(4): 255-262.
[5] Wan Chin Hsieh, Anas Aboud, Brandon M. chael Henry, Mohamed Omara, Jaroslav Lindner, Jan Pirk. Serum albumin in patients undergoing transcatheter aortic valve replacement: A meta-analysis[J]. Reviews in Cardiovascular Medicine, 2019, 20(3): 161-169.
[6] Davide Bolignano, Anna Pisano, Graziella D’Arrigo. Pulmonary hypertension: a neglected risk condition in renal patients?[J]. Reviews in Cardiovascular Medicine, 2018, 19(4): 117-121.
[7] Mazen Odish, Tomasz Beben, Lori B. Daniels. False-positive Troponin I Assay elevation due to occult Mixed Cryoglobulinemic Vasculitis[J]. Reviews in Cardiovascular Medicine, 2018, 19(2): 73-75.
[8] Nasrien E. Ibrahim, Akshay S. Desai, Jagmeet P. Singh, James L. Januzzi Jr. Advances in Heart Failure Management: Improving Outcomes With Innovation[J]. Reviews in Cardiovascular Medicine, 2017, 18(S1): 1-16.
[9] Claudio Ronco, Federico Ronco, Peter A. McCullough. A Call to Action to Develop Integrated Curricula in Cardiorenal Medicine[J]. Reviews in Cardiovascular Medicine, 2017, 18(3): 93-99.
[10] Nasrien E. Ibrahim, Akshay S. Desai, Jagmeet P. Singh, James L. Januzzi Jr. Heart Failure University 2015: Presentation Summaries[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 1-8.
[11] Peter A. McCullough, Mohammad Kazem Fallahzadeh, Refaat M. Hegazi. Nutritional Deficiencies and Sarcopenia in Heart Failure: A Therapeutic Opportunity to Reduce Hospitalization and Death[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 30-39.
[12] Marco Marchesini, Lucia Uguccioni, Rosario Parisi, Gianmaria Mattioli, Francesca Terzi, Roberto Olivieri, Alessandro Capucci, Rossella Fattori. The Role of Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy[J]. Reviews in Cardiovascular Medicine, 2016, 17(1-2): 57-64.
[13] Shadi Idris, George Degheim, Wael Ghalayini, Timothy R. Larsen, Davar Nejad, Shukri David. Home Telemedicine in Heart Failure: A Pilot Study of Integrated Telemonitoring and Virtual Provider Appointments[J]. Reviews in Cardiovascular Medicine, 2015, 16(2): 156-162.
[14] Mehrnoosh Hashemzadeh, Joseph M. Arreguin, Tyler Roberts, Mohammad Reza Movahed. A Novel Inhibitor of Protease-activated Receptor 1: A Review of Chemical Structure and Mode of Action[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 68-73.
[15] Andrés M. Pineda, Omar Issa, Mery Cortes-Bergoderi, Christos G. Mihos, Juan Carlos Brenes, Alfonso Tolentino. An Example of the Deleterious Effects of Right Ventricular Apical Pacing[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 84-89.
No Suggested Reading articles found!